Stock Analiz

CONMED Corp (CNMD) financials: revenue, earnings and cash flow

Fiscal 2016–2025 + TTM · from SEC filings · data as of November 13, 2026

Summary

CONMED’s revenue went from $764M in fiscal 2016 to $1.4B in fiscal 2025, growth of about 6.8% a year.

Net income in fiscal 2025 was $47M, a net margin of 3.4%; the best year in this period was 2024 with $132M.

Over the twelve months to September 30, 2026, revenue was $1.4B and net income $73M.

Free cash flow was $151M in fiscal 2025 and positive in 10 of the 10 years shown.

The diluted share count rose 11% over the period (dilution).

Revenue, profit and cash flow by year

Revenue
2016: $764M162017: $796M172018: $860M182019: $955M192020: $862M202021: $1.0B212022: $1.0B222023: $1.2B232024: $1.3B242025: $1.4B25$1.4B
Net income
2016: $15M162017: $55M172018: $41M182019: $29M192020: $10M202021: $63M212022: -$81M222023: $64M232024: $132M242025: $47M25$47M
Free cash flow
2016: $25M162017: $53M172018: $58M182019: $75M192020: $52M202021: $97M212022: $12M222023: $106M232024: $154M242025: $151M25$151M
EPS (diluted)
2016: $0.52162017: $1.97172018: $1.41182019: $0.97192020: $0.32202021: $1.94212022: $-2.68222023: $2.04232024: $4.25242025: $1.5125$1.51

Income statement

Fiscal yearTTM2025202420232022202120202019201820172016
Revenue$1.4B$1.4B$1.3B$1.2B$1.0B$1.0B$862M$955M$860M$796M$764M
Gross profit$788M$750M$733M$676M$571M$568M$460M$525M$469M$431M$408M
Operating income$136M$103M$200M$121M$70M$110M$46M$79M$71M$47M$38M
Net income$73M$47M$132M$64M-$81M$63M$10M$29M$41M$55M$15M
EPS (diluted)$2.41$1.51$4.25$2.04$-2.68$1.94$0.32$0.97$1.41$1.97$0.52
R&D$62M$56M$54M$53M$47M$44M$40M$45M$42M$32M$32M
Revenue growth—+5.2%+5.0%+19.1%+3.5%+17.2%−9.7%+11.1%+7.9%+4.3%+6.2%

Cash flow

Fiscal yearTTM2025202420232022202120202019201820172016
Operating cash flow$146M$171M$167M$125M$33M$112M$65M$95M$75M$66M$40M
Capital spending-$14M-$20M-$13M-$19M-$22M-$15M-$13M-$20M-$17M-$13M-$15M
Free cash flow$133M$151M$154M$106M$12M$97M$52M$75M$58M$53M$25M
Dividends paid$6M$25M$25M$25M$24M$23M$23M$23M$22M$22M$22M
Buybacks——————————$0
Stock-based pay$22M$28M$26M$24M$22M$16M$13M$12M$10M$8M$8M

Balance sheet

Fiscal yearTTM2025202420232022202120202019201820172016
Cash—$41M$24M$24M$29M$21M$27M$26M$18M$33M$27M
Debt—$887M$947M$991M$1.1B$705M$776M$793M$457M$486M$498M
Equity—$1.0B$963M$834M$746M$785M$709M$710M$662M$631M$581M
Total assets—$2.3B$2.3B$2.3B$2.3B$1.8B$1.8B$1.8B$1.4B$1.4B$1.3B
Shares (diluted)30M31M31M32M30M32M29M29M29M28M28M

Margins and returns

Fiscal yearTTM2025202420232022202120202019201820172016
Gross margin57.6%54.6%56.1%54.3%54.6%56.2%53.4%54.9%54.6%54.1%53.5%
Operating margin9.9%7.5%15.3%9.7%6.7%10.9%5.3%8.3%8.3%5.9%4.9%
Net margin5.4%3.4%10.1%5.2%-7.7%6.2%1.1%3.0%4.8%7.0%1.9%
FCF margin9.7%11.0%11.8%8.5%1.1%9.6%6.0%7.9%6.8%6.6%3.3%
ROIC—3.5%8.5%5.3%3.0%6.3%2.5%4.8%5.1%3.3%2.6%
ROE—4.5%13.8%7.7%-10.8%8.0%1.3%4.0%6.2%8.8%2.5%

Frequently asked questions

What is CONMED’s annual revenue?

$1.4B in fiscal 2025 and $1.4B over the twelve months to September 30, 2026.

How much profit does CONMED make?

Net income was $47M in fiscal 2025 (net margin 3.4%).

Is CONMED’s revenue growing?

Yes: revenue rose 5.2% in fiscal 2025 compared with the year before.

From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.